MENU
RLMD
AS OF
Feb 21 closing price
Price
$0.29
Change
-$0.02 (-6.45%)
Capitalization
8.9M
30 days until earnings call
RLMD
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$0.29
Change
-$0.02 (-6.45%)
Capitalization
8.9M
RLMD Relmada Therapeutics Chart, History Price & Graph
a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
RLMD and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENTO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENTO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To RLMD | 1D Price Change % | ||
|---|---|---|---|---|
| RLMD | 100% | -0.42% | ||
| ENTO - RLMD | 35% Loosely correlated | -2.78% | ||
| ARGNF - RLMD | 31% Poorly correlated | N/A | ||
| AVIR - RLMD | 29% Poorly correlated | -1.59% | ||
| ATXS - RLMD | 27% Poorly correlated | -0.99% | ||
| CANF - RLMD | 27% Poorly correlated | +1.96% | ||
More | ||||